Literature DB >> 17957229

Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease.

Yvonne Bombard1, Elizabeth Penziner, Oksana Suchowersky, Mark Guttman, Jane S Paulsen, Joan L Bottorff, Michael R Hayden.   

Abstract

It has been over 20 years since the inception of predictive testing for Huntington disease (HD), yet the social implications of knowing one's genetic risk for HD have not been fully explored. Genetic discrimination (GD) is a potential risk associated with predictive testing. Although anecdotal reports of GD have been documented, there is a paucity of research on the nature and experiences of GD in the context of HD. The purpose of this study was to describe the concerns and experiences of GD in the HD community. Semistructured interviews were conducted with 45 genetically tested and 10 untested individuals and analyzed using grounded theory methods. Our findings demonstrate that a majority of individuals were concerned about (37/55) and experienced GD (32/55) across a variety of contexts that extend beyond the traditionally examined contexts of insurance and employment to include family, social, government, and health-care domains. We describe a process of engagement with GD in which individuals formed meaningful interpretations of GD and personalized its risk and consequences in their lives. Our findings provide an insight into some of the specific processes and factors influencing engagement with GD. These results help identify areas where more education and support is needed and provide direction to genetic professionals supporting their clients as they confront issues of GD and genetic testing.

Entities:  

Mesh:

Year:  2007        PMID: 17957229      PMCID: PMC3806301          DOI: 10.1038/sj.ejhg.5201937

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  34 in total

1.  Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing.

Authors:  M McAllister
Journal:  Clin Genet       Date:  2003-09       Impact factor: 4.438

2.  Genetic testing and Huntington's disease: issues of employment.

Authors:  Peter S Harper; Sjef Gevers; Guido de Wert; Susan Creighton; Yvonne Bombard; Michael R Hayden
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

3.  Investigating genetic discrimination in Australia: opportunities and challenges in the early stages.

Authors:  Sandra D Taylor; Margaret F Otlowski; Kristine K Barlow-Stewart; Susan A Treloar; Mark Stranger; Kellie Chenoweth
Journal:  New Genet Soc       Date:  2004-08

4.  Predictive genetic testing and beyond: a theory of engagement.

Authors:  Marion McAllister
Journal:  J Health Psychol       Date:  2002-09

5.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

6.  Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutation.

Authors:  Y Bombard; E Penziner; J Decolongon; M L N Klimek; S Creighton; O Suchowersky; M Guttman; J S Paulsen; J L Bottorff; M R Hayden
Journal:  Clin Genet       Date:  2007-03       Impact factor: 4.438

7.  Reluctance to undergo predictive testing: the case of Huntington disease.

Authors:  K A Quaid; M Morris
Journal:  Am J Med Genet       Date:  1993-01-01

Review 8.  Cancer risk elicitation and communication: lessons from the psychology of risk perception.

Authors:  William M P Klein; Michael E Stefanek
Journal:  CA Cancer J Clin       Date:  2007 May-Jun       Impact factor: 508.702

9.  An investigation of genetic counselors' discussion of genetic discrimination with cancer risk patients.

Authors:  Nicole L Pfeffer; Patricia McCarthy Veach; Bonnie S LeRoy
Journal:  J Genet Couns       Date:  2003-10       Impact factor: 2.537

10.  Attitudes of persons at risk for Huntington disease toward predictive testing.

Authors:  S Kessler; T Field; L Worth; H Mosbarger
Journal:  Am J Med Genet       Date:  1987-02
View more
  19 in total

1.  Unravelling fears of genetic discrimination: an exploratory study of Dutch HCM families in an era of genetic non-discrimination acts.

Authors:  Els Geelen; Klasien Horstman; Carlo L M Marcelis; Pieter A Doevendans; Ine Van Hoyweghen
Journal:  Eur J Hum Genet       Date:  2012-03-28       Impact factor: 4.246

2.  Stigmatization and male identity: Norwegian males' experience after identification as BRCA1/2 mutation carriers.

Authors:  Nina Strømsvik; Målfrid Råheim; Nina Oyen; Lars Fredrik Engebretsen; Eva Gjengedal
Journal:  J Genet Couns       Date:  2010-03-20       Impact factor: 2.537

Review 3.  Global trends on fears and concerns of genetic discrimination: a systematic literature review.

Authors:  Annet Wauters; Ine Van Hoyweghen
Journal:  J Hum Genet       Date:  2016-01-07       Impact factor: 3.172

4.  Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease.

Authors:  Yvonne Bombard; JoAnne Palin; Jan M Friedman; Gerry Veenstra; Susan Creighton; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-10       Impact factor: 3.568

5.  Civilian and military genetics: nondiscrimination policy in a post-GINA world.

Authors:  Susannah Baruch; Kathy Hudson
Journal:  Am J Hum Genet       Date:  2008-10       Impact factor: 11.025

6.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

7.  Grounded theory in genetic counseling research: an interpretive perspective.

Authors:  Robin E Grubs; Maria Piantanida
Journal:  J Genet Couns       Date:  2010-02-02       Impact factor: 2.537

8.  What's at stake? Genetic information from the perspective of people with epilepsy and their family members.

Authors:  Sara Shostak; Dana Zarhin; Ruth Ottman
Journal:  Soc Sci Med       Date:  2011-07-23       Impact factor: 4.634

9.  The Genetic Non-Discrimination Act: critical for promoting health and science in Canada.

Authors:  Yvonne Bombard; Bev Heim-Myers
Journal:  CMAJ       Date:  2018-05-14       Impact factor: 8.262

Review 10.  Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.

Authors:  Scott Y H Kim; Jason Karlawish; Benjamin E Berkman
Journal:  Neurology       Date:  2015-03-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.